Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00FYF
|
||||
Former ID |
DNC005423
|
||||
Drug Name |
NVP-DPP728
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [547061] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H18N6O
|
||||
Canonical SMILES |
C1CC(N(C1)C(=O)CNCCNC2=NC=C(C=C2)C#N)C#N
|
||||
InChI |
1S/C15H18N6O/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20)/t13-/m0/s1
|
||||
InChIKey |
VFFZWMWTUSXDCB-ZDUSSCGKSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [529262] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.